What's Going On With Neurological Disease Focused Trevena On Thursday?

Loading... Loading... Shares of Trevena Inc TRVN are trading lower on Thursday, with a session volume of 23.65 million, as per data from Benzinga Pro. The company released preclinical data from two separate research collaborations. The first studies examined the cellular mechanism of analgesic effects of TRV045, a novel S1P1 receptor modulator, in a mouse model of chemotherapy-induced peripheral neuropathy (CIPN). The second set of studies was from a separate, ongoing collaboration with the NIH-supported Ep ...